The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography.

[1]  Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting StentsKuchulakanti PK, Chu WW, Torguson R, et al (Washington Hosp Ctr, Washington, DC) Circulation 113:1108–1113, 2006§ , 2008 .

[2]  Michael Joner,et al.  Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[3]  StéphaneCook,et al.  Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation , 2007 .

[4]  R. Virmani,et al.  Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.

[5]  Peter Barlis,et al.  Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[6]  Masanori Yamamoto,et al.  Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. , 2007, The American journal of cardiology.

[7]  Hiromasa Otake,et al.  Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. , 2007, European heart journal.

[8]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[9]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[10]  Seiki Nagata,et al.  Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. , 2006, Journal of the American College of Cardiology.

[11]  Fesc,et al.  Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice: One-Year Follow-Up of the e-Cypher Registry , 2006, Circulation.

[12]  Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography. , 2006, The Journal of invasive cardiology.

[13]  B. Gersh.  Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents , 2006 .

[14]  J. Popma,et al.  Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice , 2005, Circulation.

[15]  Yoshiaki Kawase,et al.  In vivo volumetric analysis of coronary stent using optical coherence tomography with a novel balloon occlusion-flushing catheter: a comparison with intravascular ultrasound. , 2005, Ultrasound in medicine & biology.

[16]  Gd Rotterdam.  Incomplete stent apposition after implantation of paclitaxel- eluting stents or bare metal stents: Insights from the randomized TAXUS II trial , 2005 .

[17]  Seung‐Jung Park,et al.  Incidence, Mechanism, Predictors, and Long-Term Prognosis of Late Stent Malapposition After Bare-Metal Stent Implantation , 2004, Circulation.

[18]  Jan J Piek,et al.  Impact of strut thickness on late luminal loss after coronary artery stent placement. , 2004, The American journal of cardiology.